149 related articles for article (PubMed ID: 9405998)
1. Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
Küpeli S; Beksac M; Küpeli B; Baltaci S; Süzer O
Int Urol Nephrol; 1997; 29(4):421-6. PubMed ID: 9405998
[TBL] [Abstract][Full Text] [Related]
2. In vitro drug sensitivity testing of human testicular germ cell tumours with cytostatic drugs and interferon alpha-2b.
Küpeli B; Baltaci S; Beksac M; Süzer O; Küpeli S; Göğüs O
Int Urol Nephrol; 1997; 29(1):79-84. PubMed ID: 9203042
[TBL] [Abstract][Full Text] [Related]
3. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
Ohmura K; Tsukamoto T
Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell lines.
Rohde D; Hayn HK; Blatter J; Jakse G
Int J Oncol; 1998 Jun; 12(6):1361-6. PubMed ID: 9592200
[TBL] [Abstract][Full Text] [Related]
5. Effect of alpha-interferon alone and combined with other antineoplastic agents on renal cell carcinoma determined by the tetrazolium microculture assay.
Homma Y; Aso Y
Eur Urol; 1994; 25(2):164-70. PubMed ID: 8137859
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of individual sensitivity to cytostatic drugs of in vitro cultured lung tumor cells.
Gebarowska E; Zabel M; Majewski A; Kołodziej J
Folia Histochem Cytobiol; 1999; 37(2):135-6. PubMed ID: 10352995
[No Abstract] [Full Text] [Related]
7. [In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
Osawa Y; Yoshida A; Asaga T; Kawahara S; Yanoma S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):471-6. PubMed ID: 8678500
[TBL] [Abstract][Full Text] [Related]
8. Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas.
Geng Y; Biffi A; Engelstein D; Ronch E; Faustini M; Lai HK; Albino AP; Di Fronzo G; Nanus DM
Anticancer Res; 1998; 18(1A):1-7. PubMed ID: 9568047
[TBL] [Abstract][Full Text] [Related]
9. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
Nygren P; Larsson R
Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
[TBL] [Abstract][Full Text] [Related]
10. Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C.
Okamoto E; Kinne RK; Sökeland J
J Urol; 1996 Oct; 156(4):1492-5. PubMed ID: 8808915
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) and vinblastine combined with interferon in nude mice xenografts of human renal cell carcinoma.
Rohde D; Goertz M; Blatter J; Jakse G
Int J Oncol; 1998 Jun; 12(6):1367-72. PubMed ID: 9592201
[TBL] [Abstract][Full Text] [Related]
12. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
May M; Helke C; Bock M; Hoschke B
Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of the chemosensitivity test using collagen gel matrix-supported culture system for urogenital tumors].
Ogihara M; Aikawa K; Ishibashi K; Irisawa C; Shiraiwa Y; Koseki K; Ishiwata H
Nihon Hinyokika Gakkai Zasshi; 1996 Apr; 87(4):740-7. PubMed ID: 8691695
[TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity testing of human renal cell carcinoma with cytostatic agents and interferon alpha-2a.
de Riese W; Allhoff E; Stief CG; Lenis G; Schlick R; Liedke S; Anton P; Jonas U
Urol Res; 1991; 19(2):87-90. PubMed ID: 1906658
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the antitumor activities of IFN-alpha8 on renal cell carcinoma cells in vitro.
Yanai Y; Horie S; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M; Kitamura T
J Interferon Cytokine Res; 2001 Dec; 21(12):1129-36. PubMed ID: 11798471
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
Jensen PB; Roed H; Sehested M; Demant EJ; Vindeløv L; Christensen IJ; Hansen HH
Cancer Chemother Pharmacol; 1992; 31(1):46-52. PubMed ID: 1360876
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cisplatin sensitivity and accumulation by interferon alpha-2A in human squamous carcinoma cell lines.
Gupta V; Jani JP; Emerson EO; Xu BH; Scalamogna D; Xia H; Katoh A; Zaren HA; Singh SV
Int J Cancer; 1995 Nov; 63(3):419-22. PubMed ID: 7591242
[TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I
Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
[TBL] [Abstract][Full Text] [Related]
20. Indomethacin enhances the cytotoxicity of VCR and ADR in human pulmonary adenocarcinoma cells.
Kobayashi S; Okada S; Yoshida H; Fujimura S
Tohoku J Exp Med; 1997 Mar; 181(3):361-70. PubMed ID: 9163851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
